|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Consolidated net income | |||||
| Adjustments to reconcile consolidated net income to net cash provided by operating activities – | |||||
| Equity in net income of affiliates | |||||
| Impairment charges | |||||
| Deferred tax benefit | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Net change in recoverable customer engineering, development and tooling | |||||
| Changes in other long-term assets | |||||
| Changes in other long-term liabilities | |||||
| Loss on extinguishment of debt | |||||
| Net change in working capital items (see below) | |||||
| Supplementary Disclosure: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds received of $29.5 million in 2025, $24.1 million in 2024 and $15.7 million in 2023 | |||||
| Changes in other long-term assets | |||||
| Changes in other long-term liabilities | |||||
| Non-cash loss on disposal of a non-core business | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Additions to property, plant and equipment | |||||
| Acquisitions, net of cash acquired | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Short-term borrowings, net | |||||
| Term loan repayments | |||||
| Term loan borrowings | |||||
| Repurchases of common stock | |||||
| Dividends paid to Lear Corporation shareholders | |||||
| Dividends paid to noncontrolling interests | |||||
| Term loan facility repayments | |||||
| Proceeds from the issuance of senior notes | |||||
| Redemption of senior notes | |||||
| Payment of debt issuance and other financing costs | |||||
| Other, net | |||||
| Net cash used in financing activities | |||||
| Effect of foreign currency translation | |||||
| Net Change in Cash, Cash Equivalents and Restricted Cash | |||||
| Cash, Cash Equivalents and Restricted Cash as of Beginning of Period | |||||
| Cash, Cash Equivalents and Restricted Cash as of End of Period | |||||
| Changes in Working Capital Items: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable (including $15.4 million of cash paid in 2023 in conjunction with the acquisition of IGB to settle pre-existing accounts payable) | |||||
| Accrued liabilities and other | |||||
Loading...